Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
Current Osteoporosis Reports - United States
doi 10.1007/s11914-010-0044-x
Full Text
Open PDFAbstract
Available in full text
Date
December 16, 2010
Authors
Publisher
Springer Science and Business Media LLC